https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33070 Wed 04 Sep 2019 10:04:24 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46299 n = 1746; 2.0%); however, these individuals had almost twice the mean costs of knee-related medical care ($1557 versus %802) and medical visits (8.4 versus 4.0). Patients with prior opioid use were more likely to have at least 1 recurrent episode of knee pain (relative risk 1.58, 95% CI 1.51, 1.65) with a higher mean number of episodes of knee pain (1.5 vs 1.8). The use of opioids with higher risk of misuse or dependency (Schedule II or III) resulted in greater medical costs (for any reason) and recurrent episodes of knee pain compared to the use of opioids in a lower risk category (Schedule IV). Conclusions: Prior opioid utilization was associated with a greater number of recurrent episodes of knee pain and higher downstream medical costs compared with individuals without prior opioid use. For individuals with prior opioid utilization, opioids with higher risk of misuse or dependency (Schedule II or III) resulted in greater medical costs (for any reason) and recurrent episodes compared to the use of lower-risk opioids (Schedule IV).]]> Tue 15 Nov 2022 15:44:08 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:9658 Sat 24 Mar 2018 08:39:29 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19907 Sat 24 Mar 2018 08:03:48 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34721 Fri 26 Apr 2019 15:58:17 AEST ]]>